Clinical Trial Update: Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia

View source ↗

Summary

This completed clinical trial evaluates the validation of a scale intended to predict relapse and short-term rehospitalization in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Janssen-Cilag, S.A. | Conditions: Schizophrenia | Status: COMPLETED